6/14
06:09 am
lxeo
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) was upgraded by analysts at Baird R W to a "strong-buy" rating.
Medium
Report
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) was upgraded by analysts at Baird R W to a "strong-buy" rating.
6/13
07:54 am
lxeo
Companies Like Lexeo Therapeutics (NASDAQ:LXEO) Are In A Position To Invest In Growth [Yahoo! Finance]
Low
Report
Companies Like Lexeo Therapeutics (NASDAQ:LXEO) Are In A Position To Invest In Growth [Yahoo! Finance]
6/13
07:38 am
lxeo
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $28.00 price target on the stock.
Low
Report
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $28.00 price target on the stock.
6/6
07:27 am
lxeo
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $22.00 price target on the stock.
Low
Report
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $22.00 price target on the stock.
5/14
02:01 pm
lxeo
What Makes Lexeo Therapeutics, Inc. (LXEO) a New Buy Stock [Yahoo! Finance]
Low
Report
What Makes Lexeo Therapeutics, Inc. (LXEO) a New Buy Stock [Yahoo! Finance]
5/14
12:04 pm
lxeo
Wall Street Analysts Think Lexeo Therapeutics, Inc. (LXEO) Could Surge 57.82%: Read This Before Placing a Bet [Yahoo! Finance]
Low
Report
Wall Street Analysts Think Lexeo Therapeutics, Inc. (LXEO) Could Surge 57.82%: Read This Before Placing a Bet [Yahoo! Finance]
5/9
07:06 am
lxeo
Lexeo Therapeutics Reports First Quarter 2024 Financial Results and Operational Highlights [Yahoo! Finance]
Medium
Report
Lexeo Therapeutics Reports First Quarter 2024 Financial Results and Operational Highlights [Yahoo! Finance]
5/9
07:00 am
lxeo
Lexeo Therapeutics Reports First Quarter 2024 Financial Results and Operational Highlights
Medium
Report
Lexeo Therapeutics Reports First Quarter 2024 Financial Results and Operational Highlights
5/7
07:30 am
lxeo
Lexeo Therapeutics to Participate in Upcoming Investor Conferences
Low
Report
Lexeo Therapeutics to Participate in Upcoming Investor Conferences
4/22
07:50 am
lxeo
Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy [Yahoo! Finance]
Medium
Report
Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy [Yahoo! Finance]
4/22
07:30 am
lxeo
Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy
Medium
Report
Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy
4/16
07:34 am
lxeo
Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich's Ataxia Cardiomyopathy [Yahoo! Finance]
Medium
Report
Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich's Ataxia Cardiomyopathy [Yahoo! Finance]
4/16
07:30 am
lxeo
Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia Cardiomyopathy
High
Report
Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia Cardiomyopathy
4/9
05:49 pm
lxeo
Lexeo: Targeted Alzheimer's Disease Treatment Approach Might Pay Off [Seeking Alpha]
Medium
Report
Lexeo: Targeted Alzheimer's Disease Treatment Approach Might Pay Off [Seeking Alpha]